Abstract:Recent years have witnessed unprecedented progress in therapeutic gene editing, revolutionizing the approach to treating genetic disorders. In this comprehensive review, we discuss the progression of milestones leading to the emergence of the clustered regularly interspaced short palindromic repeats (CRISPR)-based technology as a powerful tool for precise and targeted modifications of the human genome. CRISPR-Cas9 nuclease, base editing, and prime editing have taken center stage, demonstrating remarkable precision and efficacy in targeted ex vivo and in vivo genomic modifications. Enhanced delivery systems, including viral vectors and nanoparticles, have further improved the efficiency and safety of therapeutic gene editing, advancing their clinical translatability. The exploration of CRISPR-Cas systems beyond the commonly used Cas9, such as the development of Cas12 and Cas13 variants, has expanded the repertoire of gene editing tools, enabling more intricate modifications and therapeutic interventions. Outstandingly, prime editing represents a significant leap forward, given its unparalleled versatility and minimization of off-target effects. These innovations have paved the way for therapeutic gene editing in a multitude of previously incurable genetic disorders, ranging from monogenic diseases to complex polygenic conditions. This review highlights the latest innovative studies in the field, emphasizing breakthrough technologies in preclinical and clinical trials, and their applications in the realm of precision medicine. However, challenges such as off-target effects and ethical considerations remain, necessitating continued research to refine safety profiles and ethical frameworks.

CRISPR genome-editing grows up: advanced therapies head for the clinic

The realization of CRISPR gene therapy

Quest to use CRISPR against disease gains ground

Development and application of CRISPR/Cas9 technologies in genomic editing.

Recent Therapeutic Gene Editing Applications to Genetic Disorders

Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease

CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future

RNA in Therapeutics: CRISPR in the Clinic

Progress in the application of gene editing technology in cancer treatmentstaking CRISPR as an example

The History, Use, and Challenges of Therapeutic Somatic Cell and Germline Gene Editing

Move over, CRISPR: RNA-editing therapies pick up steam

CASGEVY Makes History as FDA Approves First CRISPR/Cas9 Genome Edited Therapy

CRISPR-engineered T cells in patients with refractory cancer

CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine

Emerging CRISPR Therapies for Precision Gene Editing and Modulation in the Cardiovascular Clinic

CRISPR/Cas9-mediated genome editing: from basic research to gene therapy

Applications of CRISPR technologies to the development of gene and cell therapy

CRISPR technology: A decade of genome editing is only the beginning

The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy

Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics

CRISPR and Gene Editing: A Game-Changer in Drug Development